Luigino Calzetta

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 339 publications

Current perspectives on β2-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.

Current perspectives on β2-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.

Journal: Expert opinion on pharmacotherapy

Published: July 14, 2026

Mucus plugs in COPD and cardiovascular mortality: An emerging risk pathway and the therapeutic potential of mucolytic strategies.

Mucus plugs in COPD and cardiovascular mortality: An emerging risk pathway and the therapeutic potential of mucolytic strategies.

Journal: Respiratory medicine

Published: March 31, 2026

Emerging pharmacotherapies in chronic rhinosinusitis with nasal polyps.

Emerging pharmacotherapies in chronic rhinosinusitis with nasal polyps.

Journal: Expert opinion on pharmacotherapy

Published: February 28, 2026

Low-dose ensifentrine exerts anti-inflammatory effects comparable to roflumilast in COPD airways.

Low-dose ensifentrine exerts anti-inflammatory effects comparable to roflumilast in COPD airways.

Journal: American journal of respiratory cell and molecular biology

Published: February 18, 2026

Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implications.

Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implications.

Journal: Expert opinion on drug metabolism & toxicology

Published: February 13, 2026

Current and Emerging Biologic Therapies for Severe Asthma.

Current and Emerging Biologic Therapies for Severe Asthma.

Journal: Drugs

Published: February 07, 2026

Exploring AI and ML in managing overlap between cardiovascular disease and asthma or COPD: a scoping review.

Exploring AI and ML in managing overlap between cardiovascular disease and asthma or COPD: a scoping review.

Journal: Respiratory medicine

Published: January 07, 2026

Bronchorelaxant and anti-inflammatory profile of ensifentrine alone and combined with inhaled medications in lipopolysaccharide-challenged human airways from chronic obstructive pulmonary disease donors.

Bronchorelaxant and anti-inflammatory profile of ensifentrine alone and combined with inhaled medications in lipopolysaccharide-challenged human airways from chronic obstructive pulmonary disease donors.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 19, 2025

GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care.

GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care.

Journal: Drugs

Published: December 17, 2025

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications.

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications.

Journal: Frontiers in physiology

Published: October 29, 2025

Mucus as a Treatable Trait in Chronic Airway Diseases.

Mucus as a Treatable Trait in Chronic Airway Diseases.

Journal: Drugs

Published: October 20, 2025

Efficacy of tezepelumab in reducing oral corticosteroid use in severe asthma.

Efficacy of tezepelumab in reducing oral corticosteroid use in severe asthma.

Journal: The Lancet. Respiratory medicine

Published: October 19, 2025

Showing 1-12 of 339

Last Updated: 09/26/2026